Pathophysiology of the endothelin system - lessons from genetically manipulated animal models

被引:0
作者
K. von Websky
S. Heiden
T. Pfab
B. Hocher
机构
[1] Center for Cardiovascular Research,Department of Pharmacology
[2] Charité - Campus Benjamin Franklin,Department of Nephrology
关键词
Enteric Neuron; Renal Sympathetic Nerve Activity; Collect Duct; Epidermal Melanocyte; Fibrotic Remodelling;
D O I
10.1186/2047-783X-14-1-1
中图分类号
学科分类号
摘要
Shortly after discovery of ET-1 in 1988, the entire endothelin system was characterized. The endothelin system consists of the three peptides ET-1, ET-2 and ET-3, their G-protein-coupled receptors endothelin receptor A and B (ETRA and ETRB) and the two endothelin-converting enzymes (ECE-1 and ECE-2). Genetically modified animal models are an important tool in biomedical research. Here we describe the key findings obtained from genetically modified animal models either over-expressing compounds of the ET system or lacking these compounds (knockout mice). Results from the different transgenic and knockout models disclose that the ET system plays a major role in embryonic development. Two ET system-dependent neural crest-driven developmental pathways become obvious: one of them being an ET-1/ETAR axis, responsible for cardio-renal function and development as well as cranial development; the other seems to be an ET-3/ETBR mediated signalling pathway. Mutations within this axis are associated with disruptions in epidermal melanocytes and enteric neurons. These findings led to the discovery of similar findings in humans with Hirschsprung disease. In adult life the ET system is most important in the cardiovascular system and plays a role in fibrotic remodelling of the heart, lung and kidney as well as in the regulation of water and salt excretion.
引用
收藏
相关论文
共 266 条
  • [1] Kedzierski RM(2001)Endothelin system: The double-edged sword in health and disease Annual Review of Pharmacology and Toxicology 41 851-876
  • [2] Yanagisawa M(1997)Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension Journal of Clinical Investigation 99 1380-1389
  • [3] Hocher B(2002)Renal damage and salt-dependent hypertension in aged transgenic mice overexpressing endothelin-1 Journal of Molecular Medicine-JMM 80 105-116
  • [4] ThoneReineke C(1988)A Novel Potent Vasoconstrictor Peptide Produced by Vascular Endothelial-Cells Nature 332 411-415
  • [5] Rohmeiss P(1997)The paracrine endothelin system: Pathophysiology and implications in clinical medicine European Journal of Clinical Chemistry and Clinical Biochemistry 35 175-189
  • [6] Schmager F(1999)Pathophysiology of endothelin in the cardiovascular system Annual Review of Physiology 61 391-415
  • [7] Slowinski T(1998)The role of endothelin in hypertension Current Opinion in Nephrology and Hypertension 7 451-456
  • [8] Burst V(1999)Transgenic rats expressing the human ET-2 gene: a model for the study of endothelin actions in vivo Journal of Molecular Medicine-JMM 77 565-574
  • [9] Shindo T(2004)In-vivo interaction of nitric oxide and endothelin J Hypertens 22 111-119
  • [10] Kurihara H(2007)Lack of endothelial nitric oxide synthase promotes endothelin-induced hypertension: Lessons from endothelin-1 transgenic/endothelial nitric oxide synthase knockout mice Journal of the American Society of Nephrology 18 730-740